| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.017 | 0.6 |
| mRNA | darinaparsin | CTRPv2 | pan-cancer | AAC | -0.025 | 0.6 |
| mRNA | GDC-0449 | FIMM | pan-cancer | AAC | 0.082 | 0.6 |
| mRNA | AZD6482 | GDSC1000 | pan-cancer | AAC | -0.015 | 0.6 |
| mRNA | BRD-K33199242 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | Sunitinib | GDSC1000 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | -0.035 | 0.6 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | SR1001 | CTRPv2 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.015 | 0.6 |